BIO-key International, Inc. (BKYI) vs RTX Corporation (RTX)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Sep 16, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| BKYI | RTX | |
|---|---|---|
| Sector | Industrials | Industrials |
| Industry | Security & Protection Services | Aerospace & Defense |
| Size band | NANO | MEGA |
| Listing | PNK | NYSE |
| Country | United States | United States |
| Theme | cybersecurity | defense-prime-contractors |
| Price and returns | ||
| Last close | $4.13 | $197.48 |
| Return · 1 week | −1.67% | +2.80% |
| Return · 1 month | −20.88% | +5.23% |
| Return · 3 months | −33.39% | −9.65% |
| Return · year to date | −30.00% | +6.25% |
| Return · 1 year | −50.83% | +11.44% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −79.04% | −12.96% |
| 52-week high | $19.70 | $226.88 |
| 52-week low | $3.10 | $166.74 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $4.48M | $257.76B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $48.53K | $750.47M |
| Employees | 41 | 180,000 |
| Valuation | ||
| Price to earnings · trailing | — | 34.14× |
| Price to earnings · forward | — | 24.64× |
| Price to sales | — | 2.80× |
| Price to book | — | 3.94× |
| Enterprise value to EBITDA | — | 18.48× |
| Enterprise value to revenue | — | 3.14× |
| PEG ratio | — | 2.25 |
| Earnings per share · trailing | — | 5.68 |
| Profitability | ||
| Gross margin | — | 20.35% |
| Operating margin | — | 12.70% |
| Profit margin | — | 8.28% |
| Return on equity | — | 12.27% |
| Return on assets | — | 4.21% |
| Growth | ||
| Revenue growth | — | +14.50% |
| Earnings growth | — | +28.70% |
| Balance sheet and payout | ||
| Debt / equity (%) | — | 57.02 |
| Current ratio | — | 1.01 |
| Dividend yield | — | 1.51% |
| Payout ratio | — | 48.77% |
| Trend and volatility | ||
| RSI · 14 | — | 49.90 |
| ADX · 14 | — | 32.36 |
| 50-day average | — | $197.11 |
| 200-day average | — | $195.18 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | — | 2.44% |
The full BKYI analysis
Everything this table leaves out for BIO-key International, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the BKYI argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full BKYI analysisThe full RTX analysis
Everything this table leaves out for RTX Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the RTX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full RTX analysis